Investigation of the Passerini and Ugi reactions in β-lactam aldehydes. Synthetic applications.

Org Biomol Chem

Grupo de Lactamas y Heterociclos Bioactivos, Departamento de Química Orgánica I, Unidad Asociada al CSIC, Facultad de Química, Universidad Complutense de Madrid, 28040-Madrid, Spain.

Published: February 2015

Passerini (P-3CR) and Ugi (U-4CR) reactions were investigated in 4-oxoazetidine-2-carboxaldehydes, affording the corresponding Passerini and Ugi adducts with moderate diastereoselectivity in high yields. Fortunately, the obtained mixtures of isomers syn/anti were separated in most cases. The scope of both IMCRs has been studied using a variety of isocyanides, carboxylic acids and amines. Ugi adducts were used for the preparation of unusual 2-azetidinones fused to medium-sized rings via RCM. In addition, β-lactam-diketopiperazine hybrids have also been prepared from the corresponding Ugi adducts.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c4ob02289kDOI Listing

Publication Analysis

Top Keywords

ugi adducts
12
passerini ugi
8
ugi
5
investigation passerini
4
ugi reactions
4
reactions β-lactam
4
β-lactam aldehydes
4
aldehydes synthetic
4
synthetic applications
4
applications passerini
4

Similar Publications

In search for new molecules of diterpene origin with promising anticancer activity, two amino-derivatives (methyl maleopimarate aminoimide and methyl 1β,13-epoxydihydroquinopimarate C4-hydrazone) were involved in the 4-component Ugi reaction (Ugi-4CR) and pseudo-7-component azido-Ugi condensation (azido-Ugi-7CR) to afford a series of adducts holding α-aminoacylamide and bis-1,5-disubstituted tetrazole substituents. The NCI-60 cancer cell panel screening revealed diterpene-type Ugi adducts 2, 5, and 6 with strong antiproliferative potency with GI in range of 1.2-15.

View Article and Find Full Text PDF

Natural compounds, including diterpenoids, play a critical role in various biological processes and are recognized as valuable components in cancer treatment. Isocyanides multicomponent reactions (IsMCRs) are one of the effective methods to obtain adducts at the carboxyl group with a peptide-like substituent. In this study, dehydroabietic acid and levopimaric acid diene adducts as the starting scaffolds were modified by the multicomponent Passerini (P-3CR) and Ugi (U-4CR) reactions to afford α-acyloxycarboxamides and α-acylaminocarboxamides.

View Article and Find Full Text PDF

Piperazines and diazepines are examples of nitrogen heterocycles present in many marketed drugs highlighting their importance in the discovery of novel bioactive compounds. However, their synthesis often faces challenges, including complex functionalization and lengthy reaction sequences. Multicomponent reactions, notably the Ugi reaction, have emerged as powerful tools to address these hurdles.

View Article and Find Full Text PDF

A Cu-catalyzed tandem transformation of Ugi adducts through CH/NH bond functionalization reactions was reported for synthesizing a broad spectrum of indolo/pyrrolo-[1,2-]quinoxaline-6/4-carboxamide, 7-indolo[2,3-]quinoline-6-carboxamide, and 1-(cyclohexylamino)-14-indolo[2,3-][1,4]oxazino[4,3-]quinolin-4(3)-one derivatives in moderate to excellent yields. In this protocol the Ugi condensation of aromatic aldehydes, anilines, acids, and isocyanides leads to the formation of bis-amides in methanol at room temperature. This approach employed simple reaction conditions, including Ugi product as starting material, CuI, l-proline as a ligand, and cesium carbonate, in DMSO for 8 h.

View Article and Find Full Text PDF

Two tandem catalytic systems are described for the synthesis of novel 3,4-disubstituted maleimides using the same Ugi adducts as starting materials. 4-Aryl-3-pyrrolyl- and 4-aryl-3-indolyl-maleimides were successfully obtained a Pd(OAc)/PPh based protocol. In contrast, maleimide-fused pyrrolo and indolo[1,2-]quinolines were obtained in a complementary methodology using CuI/L-proline.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!